Advertisement

Foundations and Principles

Chapter
Part of the SpringerBriefs in Public Health book series (BRIEFSPUBLIC)

Abstract

HIV prevention ultimately depends on people taking action to protect themselves and others from becoming infected. This chapter discusses the behavioral basis for HIV prevention and the principles of behavior change that are most relevant to implementing HIV treatments as prevention (TasP). Behavioral interventions have proven effective at reducing sexual and drug use practices, preventing sexually transmitted infections including HIV transmission, and improving medication adherence. These strategies are essential for integration with TasP and creative theoretical models are needed for combining interventions. The new age of HIV prevention we are entering will also require new principles for TasP including effectively communicating partial protection, reducing risk compensation, maintaining adherence, and capitalizing on teachable moments.

Keywords

Behavioral Intervention Sexually Transmitted Infection Male Circumcision Female Condom Teachable Moment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kalichman SC, Belcher L, Cherry C, Williams E. Primary prevention of sexually transmitted HIV infections: transferring behavioral research to community programs. J Prim Prev. 1997;18:149–72.CrossRefGoogle Scholar
  2. 2.
    Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand’s HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet. 1994;344(8917):243–5. Epub 23 July 1994.PubMedCrossRefGoogle Scholar
  3. 3.
    Stoneburner RL, Low-Beer D. Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia. Int J Epidemiol. 2004;33(3):624. Epub 12 June 2004.PubMedCrossRefGoogle Scholar
  4. 4.
    Slutkin G, Okware S, Naamara W, Sutherland D, Flanagan D, Carael M, et al. How Uganda reversed its HIV epidemic. AIDS Behav. 2006;10(4):351–60. Epub 22 July 2006.PubMedCrossRefGoogle Scholar
  5. 5.
    Merson M. Uganda’s HIV/AIDS Epidemic: Guest Editorial. AIDS Behav. 2006;10:333–4.CrossRefGoogle Scholar
  6. 6.
    Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977–87. Epub 9 Nov 2008.PubMedCrossRefGoogle Scholar
  7. 7.
    Dunne EF, Whitehead S, Sternberg M, Thepamnuay S, Leelawiwat W, McNicholl JM, et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr. 2008;49(1):77–83. Epub 1 Aug 2008.PubMedCrossRefGoogle Scholar
  8. 8.
    Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9630):2109–19. Epub 24 June 2008.PubMedCrossRefGoogle Scholar
  9. 9.
    Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;358(15):1560–71. Epub 14 Mar 2008.PubMedCrossRefGoogle Scholar
  10. 10.
    El-Bassel N, Jemmott JB, Landis JR, Pequegnat W, Wingood GM, Wyatt GE, et al. National Institute of Mental Health Multisite Eban HIV/STD Prevention Intervention for African American HIV Serodiscordant Couples: a cluster randomized trial. Arch Intern Med. 2010;170(17):1594–601. Epub 14 July 2010.PubMedCrossRefGoogle Scholar
  11. 11.
    Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ, Garnett GP. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One. 2008;3(5):e2212. Epub 22 May 2008.PubMedCrossRefGoogle Scholar
  12. 12.
    Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med. 2006;3(7):e262. Epub 11 July 2006.PubMedCrossRefGoogle Scholar
  13. 13.
    Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav. 2008;12(3):335–53. Epub 27 Sept 2007.PubMedCrossRefGoogle Scholar
  14. 14.
    Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98. Epub 16 Nov 2011.PubMedCrossRefGoogle Scholar
  15. 15.
    Scott-Sheldon LA, Fielder RL, Carey MP. Sexual risk reduction interventions for patients attending sexually transmitted disease clinics in the United States: a meta-analytic review, 1986 to early 2009. Ann Behav Med. 2010;40(2):191–204. Epub 24 July 2010.PubMedCrossRefGoogle Scholar
  16. 16.
    Lagakos SW, Gable AR. Challenges to HIV prevention–seeking effective measures in the absence of a vaccine. N Engl J Med. 2008;358(15):1543–5. Epub 12 Apr 2008.PubMedCrossRefGoogle Scholar
  17. 17.
    Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24(5):621–35 Epub 25 Feb 2010.PubMedCrossRefGoogle Scholar
  18. 18.
    Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61. Epub 17 July 2007.PubMedCrossRefGoogle Scholar
  19. 19.
    Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50. Epub 6 July 2004.PubMedCrossRefGoogle Scholar
  20. 20.
    Chesney MA, Koblin BA, Barresi PJ, Husnik MJ, Celum CL, Colfax G, et al. An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. Am J Public Health. 2003;93(6):933–8. Epub 30 May 2003.PubMedCrossRefGoogle Scholar
  21. 21.
    Kamb M, Fishbein M, Douglas J, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases. J Am Med Assoc. 1998;280(13):1161–7.CrossRefGoogle Scholar
  22. 22.
    Investigators E. HIVNET 015 executive summary [protocol document available from the study team]. 2004; In press.Google Scholar
  23. 23.
    Stall R, Duran L, Wisniewski SR, Friedman MS, Marshal MP, McFarland W, et al. Running in place: implications of HIV incidence estimates among urban men who have sex with men in the United States and other industrialized countries. AIDS Behav. 2009;13(4):615–29. Epub 12 Feb 2009.PubMedCrossRefGoogle Scholar
  24. 24.
    Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97. Epub 17 Mar 2006.PubMedCrossRefGoogle Scholar
  25. 25.
    Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515–21. Epub 24 Oct 2008.PubMedCrossRefGoogle Scholar
  26. 26.
    Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98. Epub 16 Jan 2004.PubMedGoogle Scholar
  27. 27.
    Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783. Epub 31 July 2008.PubMedCrossRefGoogle Scholar
  28. 28.
    DiIorio C, McCarty F, Resnicow K, McDonnell Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83. Epub 21 Mar 2008.PubMedCrossRefGoogle Scholar
  29. 29.
    DiIorio C, Resnicow K, McDonnell M, Soet J, McCarty F, Yeager K. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14(2):52–62. Epub 18 Apr 2003.PubMedCrossRefGoogle Scholar
  30. 30.
    de Bruin M, Viechtbauer W, Hospers HJ, Schaalma HP, Kok G. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects. Health Psychol. 2009;28(6):668–74. Epub 18 Nov 2009.PubMedCrossRefGoogle Scholar
  31. 31.
    Amico KR. Standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th international conference on HIV treatment adherence. J Int Assoc Physicians AIDS Care (Chic). 2011;10(5):291–6. Epub 12 May 2011.CrossRefGoogle Scholar
  32. 32.
    Rotheram-Borus MJ, Ingram BL, Swendeman D, Flannery D. Common principles embedded in effective adolescent HIV prevention programs. AIDS Behav. 2009;13(3):387–98. Epub 19 Feb 2009.PubMedCrossRefGoogle Scholar
  33. 33.
    Rotheram-Borus MJ, Swendeman D, Flannery D, Rice E, Adamson DM, Ingram B. Common factors in effective HIV prevention programs. AIDS Behav. 2009;13(3):399–408. Epub 3 Oct 2008.PubMedCrossRefGoogle Scholar
  34. 34.
    Ingram BL, Flannery D, Elkavich A, Rotheram-Borus MJ. Common processes in evidence-based adolescent HIV prevention programs. AIDS Behav. 2008;12(3):374–83. Epub 12 Mar 2008.PubMedCrossRefGoogle Scholar
  35. 35.
    Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ. 2006;332(7541):605–7. Epub 11 Mar 2006.PubMedCrossRefGoogle Scholar
  36. 36.
    Phillips KA, Coates TJ. HIV counselling and testing: research and policy issues. AIDS Care. 1995;7(2):115–24. Epub 1 Jan 1995.PubMedCrossRefGoogle Scholar
  37. 37.
    Bogard E, Kuntz KM. The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model. J Acquir Immune Defic Syndr. 2002;29(2):132–41. Epub 8 Feb 2002.PubMedGoogle Scholar
  38. 38.
    Crosby RA, Holtgrave DR. Will sexual risk behaviour increase after being vaccinated for AIDS? Int J STD AIDS. 2006;17(3):180–4. Epub 3 Mar 2006.PubMedCrossRefGoogle Scholar
  39. 39.
    Pinkerton SD. Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal. 2001;21(4):727–36. Epub 1 Dec 2001.PubMedCrossRefGoogle Scholar
  40. 40.
    Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369:643–56.PubMedCrossRefGoogle Scholar
  41. 41.
    Eaton LA, Kalichman SC. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4:165–72.PubMedCrossRefGoogle Scholar
  42. 42.
    Kalichman S, Eaton L, Pinkerton S. Circumcision for HIV prevention: failure to fully account for behavioral risk compensation. PLoS Med. 2007;4(3):e138. author reply e46. Epub 29 Mar 2007.PubMedCrossRefGoogle Scholar
  43. 43.
    Eaton L, Kalichman SC. Behavioral aspects of male circumcision for the prevention of HIV infection. Curr HIV/AIDS Rep. 2009;6(4):187–93. Epub 24 Oct 2009.PubMedCrossRefGoogle Scholar
  44. 44.
    Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74. Epub 21 July 2010.PubMedCrossRefGoogle Scholar
  45. 45.
    Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99. Epub 26 Nov 2010.PubMedCrossRefGoogle Scholar
  46. 46.
    Weinhardt LS, Mosack KE, Swain GR. Development of a computer-based risk-reduction counseling intervention: acceptability and preferences among low-income patients at an urban sexually transmitted infection clinic. AIDS Behav. 2007;11(4):549–56. Epub 10 Oct 2006.PubMedCrossRefGoogle Scholar
  47. 47.
    Grimley DM, Hook 3rd EW. A 15-minute interactive, computerized condom use intervention with biological endpoints. Sex Transm Dis. 2009;36(2):73–8. Epub 7 Jan 2009.PubMedCrossRefGoogle Scholar
  48. 48.
    Bellis JM, Grimley DM, Alexander LR. Feasibility of a tailored intervention targeting STD-related behaviors. Am J Health Behav. 2002;26(5):378–85. Epub 11 Sept 2002.PubMedCrossRefGoogle Scholar
  49. 49.
    Fisher JD, Amico KR, Fisher WA, Cornman DH, Shuper PA, Trayling C, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav. 2011;15(8):1635–46. Epub 1 Apr 2011.PubMedCrossRefGoogle Scholar
  50. 50.
    Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, Frank I, et al. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008;47(1):62–8. Epub 25 Sept 2007.PubMedCrossRefGoogle Scholar
  51. 51.
    Senore C, Giordano L, Bellisario C, Di Stefano F, Segnan N. Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature. Front Oncol. 2012;2:45. Epub 1 June 2012.PubMedCrossRefGoogle Scholar
  52. 52.
    McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–70. Epub 6 May 2003.PubMedCrossRefGoogle Scholar
  53. 53.
    McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 2003;10(4):325–33. Epub 14 Aug 2003.PubMedGoogle Scholar
  54. 54.
    UNAIDS. Combination HIV prevention: tailoring and coordinating biomedical, behavioural and structural strategies to reduce new HIV infections: a UNAIDS discussion paper. Geneva, Switzerland, 2010.Google Scholar
  55. 55.
    Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372(9639):669–84. Epub 9 Aug 2008.PubMedCrossRefGoogle Scholar
  56. 56.
    Tatoud RJ. Metaphors of HIV prevention: 1. The HIV prevention buffet. 2011 [cited 2012]. http://www.incidence0.org/2011/05/31/metaphors-of-hiv-prevention-1-the-hiv-prevention-buffet/.

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Center for HIV Intervention and PreventionUniversity of ConnecticutStorrsUSA

Personalised recommendations